• Radiobiology of alpha emitters : development of an in vitro tumor model of targeted alpha-therapy
    Jacquet C, Oger R, Gouard S, Eychenne R, Maingueneau C, Ligeour M, Guérard F, Chérel M, Gaschet J, Guilloux Y, Allard M
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 2-8 octobre 2022

  • Radio-immuno-biologie des particules alpha : développement et étude d’un modèle in vitro de radiothérapie interne vectorisée alpha anti-tumorale
    Jacquet C, Laurent N, Oger R, Gouard S, Eychenne R, Maingueneau C, Ligeour M, Guérard F, Chérel M, Gaschet J, Guilloux Y, Allard M
    1er congrès de la Société Française de Biologie des Radiations, St Raphaël, France, 7-9 novembre 2022

  • Radiothérapie interne vectorisée alpha pour le traitement de la leucémie aigüe myéloblastique
    Sorin M, Gouard S, Marionneau-Lambot S, Eychenne R, Maingueneau C, Ligeour M, Guilloux Y, Allard M, Guérard F, Chérel M, Gaschet J
    1er congrès de la Société Française de Biologie des Radiations, St Raphaël, France, 7-9 novembre 2022

  • Targeted Alpha-Therapy for the treatment of Acute Myeloid Leukemia
    Sorin M, Gouard S, Marionneau-Lambot S, Eychenne R, Maingueneau C, Ligeour M, Guilloux Y, Allard M, Guérard F, Chérel M, Gaschet J
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Development and PET/CT preclinical evaluation of anti-CXCR4 antibody in triple-negative breast cancer (TNBC) murine model
    Métivier C, El Ayoubi N, Le Saëc P, Garcion E, Tripier R, Haddad F, Chérel M, Huclier S, Faivre-Chauvet A, Rbah-Vidal L
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Neutral Copper(II) TE1PA-based chelate for 64Cu-PET imaging : when an additional carboxyl group makes the difference
    Pineau J, Lima LMP, Marionneau-Lambot S, Le Saëc P, Faivre-Chauvet A, Zeevaart JR, Driver CHS, Le Bris N, Tripier R
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Tracking CXCR4 with a small synthetic organic vector : chelator conjugation, 64Cu radiolabelling and in vivo targeted-PET imaging
    Le Roy M, Le Saëc P, Chérel M, Faivre-Chauvet A, Troadec T, Tripier R
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Evaluation of peptide receptor radionuclide therapy using 225Ac-DOTATOC in a mouse model of liver metastases of pancreatic neuroendocrine tumor
    Lugat A, Marionneau-Lambot S, Gouard S, Frampas E, Faivre-Chauvet A, Morgenstern A, Bruchersteifer F, Chérel M, Kraeber-Bodéré F, Ansquer C, Gaschet J
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Targeting of circulating tumor cells in triple negative breast cancer
    Laurent N, Marionneau-Lambot S, Gouard S, Heymann D, Maingueneau C, Haddad F, Lepareur N, Guilloux Y, Chérel M
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Radiobiology of alpha emitters : development of an in vitro tumor model of targeted alpha-therapy
    Jacquet C, Oger R, Gouard S, Eychenne R, Maingueneau C, Ligeour M, Guérard F, Chérel M, Gaschet J, Guilloux Y, Allard M
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022